Healthcare stocks were declining premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1.5% lower and the iShares Biotechnology ETF (IBB) down 0.9%.
Moderna (MRNA) shares were up 1.5% after the company swung to Q3 earnings on higher revenue, and raised its 2026 revenue outlook.
Eli Lilly (LLY) and Hims & Hers Health (HIMS) said they signed an agreement to expand patient access to Eli Lilly's weight loss medicines Zepbound and Foundayo. Hims & Hers Health stock was up more than 7% pre-bell.
Humana (HUM) was down 0.6% after the company reported that it swung to a Q3 adjusted loss.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.